Cubist Systematic Strategies’s Accendra Health ACH Stock Holding History

Cubist Systematic Strategies’s Portfolio ACH Stock Details ACH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	$593K	Sell	123,630 -43,765	-26%	-$278K	﹤0.01%	2193
2025 Q2	$1.52M	Sell	167,395 -159,787	-49%	-$1.18M	0.01%	1705
2025 Q1	$2.95M	Buy	+327,182	New	+$3.45M	0.02%	1184
2024 Q2	–	Sell	-54,031	Closed	-$1.5M	–	3738
2024 Q1	$1.5M	Sell	54,031 -244,864	-82%	-$5.44M	0.01%	1861
2023 Q4	$5.76M	Buy	298,895 +148,103	+98%	+$2.68M	0.04%	783
2023 Q3	$2.44M	Sell	150,792 -138,548	-48%	-$2.46M	0.02%	1231
2023 Q2	$5.51M	Buy	289,340 +151,818	+110%	+$2.71M	0.04%	784
2023 Q1	$2M	Buy	137,522 +59,520	+76%	+$1.07M	0.01%	1674
2022 Q4	$1.52M	Buy	+78,002	New	+$1.52M	0.01%	2083
2022 Q3	–	Sell	-39,899	Closed	-$1.25M	–	4638
2022 Q2	$1.25M	Buy	39,899 +19,770	+98%	+$716K	0.01%	2276
2022 Q1	$886K	Buy	20,129 +12,821	+175%	+$551K	0.01%	2130
2021 Q4	$318K	Sell	7,308 -12,840	-64%	-$503K	﹤0.01%	2755
2021 Q3	$630K	Sell	20,148 -138,514	-87%	-$5.45M	0.01%	1869
2021 Q2	$6.72M	Buy	158,662 +37,049	+30%	+$1.44M	0.08%	380
2021 Q1	$4.57M	Sell	121,613 -10,435	-8%	-$326K	0.06%	496
2020 Q4	$3.57M	Sell	132,048 -11,814	-8%	-$304K	0.05%	618
2020 Q3	$3.61M	Buy	143,862 +54,955	+62%	+$801K	0.05%	563
2020 Q2	$677K	Sell	88,907 -69,377	-44%	-$508K	0.01%	1416
2020 Q1	$1.45M	Buy	158,284 +154,056	+3,644%	+$930K	0.04%	622
2019 Q4	$22K	Sell	4,228 -151,398	-97%	-$972K	﹤0.01%	2340
2019 Q3	$904K	Buy	155,626 +27,376	+21%	+$123K	0.02%	1017
2019 Q2	$410K	Sell	128,250 -74,836	-37%	-$255K	0.01%	1613
2019 Q1	$833K	Buy	203,086 +41,575	+26%	+$263K	0.03%	855
2018 Q4	$1.02M	Buy	+161,511	New	+$1.68M	0.05%	555
2018 Q3	–	Sell	-26,551	Closed	-$444K	–	2025
2018 Q2	$444K	Sell	26,551 -51,110	-66%	-$827K	0.02%	858
2018 Q1	$1.21M	Buy	77,661 +45,369	+140%	+$809K	0.07%	360
2017 Q4	$610K	Buy	32,292 +24,468	+313%	+$543K	0.03%	762
2017 Q3	$228K	Sell	7,824 -2,426	-24%	-$71.6K	0.01%	1361
2017 Q2	$330K	Sell	10,250 -5,800	-36%	-$190K	0.02%	969
2017 Q1	$555K	Buy	16,050 +15,393	+2,343%	+$550K	0.04%	591
2016 Q4	$23K	Sell	657 -10,005	-94%	-$338K	﹤0.01%	1629
2016 Q3	$370K	Buy	+10,662	New	+$373K	0.02%	879
2016 Q2	–	Sell	-41,036	Closed	-$1.66M	–	1831
2016 Q1	$1.66M	Buy	41,036 +6,529	+19%	+$243K	0.09%	279
2015 Q4	$1.24M	Buy	34,507 +28,178	+445%	+$1.02M	0.07%	377
2015 Q3	$202K	Buy	6,329 +1,070	+20%	+$36.4K	0.01%	1477
2015 Q2	$179K	Sell	5,259 -16,262	-76%	-$548K	0.01%	1477
2015 Q1	$728K	Buy	21,521 +20,172	+1,495%	+$703K	0.04%	728
2014 Q4	$47K	Buy	+1,349	New	+$45.4K	﹤0.01%	1778
2014 Q3	–	Sell	-12,235	Closed	-$416K	–	1840
2014 Q2	$416K	Buy	+12,235	New	+$419K	0.03%	816

Other funds holding ACH

CCM

Coliseum Capital Management Rowayton, Connecticut $1.22B AUM 18.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

ICM

Invenomic Capital Management Boston, Massachusetts $2.18B AUM 0.03% 1-Year Est. Return

PCMI

Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Cubist Systematic Strategies's ACH Position: Q3 2025 in Review

Cubist Systematic Strategies reduced its Accendra Health (ACH) stake by 26% in Q3 2025, selling an estimated $278K and leaving 123,630 shares worth $593K. The position accounts for ﹤0.01% of the portfolio, ranked #2193.

Cubist Systematic Strategies first reported a position in ACH in Q2 2014 and has held it in 39 quarters since. The position peaked at $6.72M in Q2 2021. 202 funds tracked by Wall St. Rank hold ACH as of Q3 2025.

Cubist Systematic Strategies held 123,630 shares of Accendra Health worth $593K as of Q3 2025.
Cubist Systematic Strategies sold 43,765 Accendra Health shares in Q3 2025, an estimated $278K.
Accendra Health made up ﹤0.01% of Cubist Systematic Strategies's portfolio in Q3 2025, its #2193 holding.
Cubist Systematic Strategies first reported a position in Accendra Health in Q2 2014 and has held it in 39 quarters since.
Cubist Systematic Strategies's Accendra Health position peaked at $6.72M in Q2 2021.
202 funds tracked by Wall St. Rank held Accendra Health as of Q3 2025.

Based on Cubist Systematic Strategies's 13F filing for Q3 2025, filed 14 Nov 2025.